Related Articles
Long non‑coding RNA H19 is involved in sorafenib resistance in hepatocellular carcinoma by upregulating miR‑675
Sorafenib combined with gemcitabine in EGFR‑TKI‑resistant human lung cancer cells
Combined therapeutic efficacy of 188Re‑liposomes and sorafenib in an experimental colorectal cancer liver metastasis model by intrasplenic injection of C26‑luc murine colon cancer cells
Inhibition of autophagy enhances the targeted therapeutic effect of sorafenib in thyroid cancer
Combination treatment with sorafenib and wh‑4 additively suppresses the proliferation of liver cancer cells